104-week efficacy and safety of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease: a phase III open-label extension study (ATB200-07)
Article in Journal of Neurology (February 2024)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Article in Journal of Neurology (February 2024)
Article in Journal of Patient-Reported Outcomes (January 2024)
Preprint in Research Square (December 2023)